Clinical Trials Logo
  1. Home
  2. Pseudarthrosis
  3. NCT06103396

Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) — MSC  

Pseudarthrosis Clinical Trial

Official title:
Treatment of Nonunion After Fractures (Pseudoartrosis) Using Mesenchymal Stromal Cells (MSCs)

Clinical Trial Summary

The goal of this study is to evaluate the bone regeneration capacity of BM-MSC (Bone marrow mesenchymal stromal cells), in patients with nonunion. BM-MSC cultured are seeded on a collagen scaffold, included into autologous platelet-rich plasma (PRP) clot, and implanted in the nonunion bone defect.

Clinical Trial Description

Nonunion (pseudoarthrosis) is one of the most serious complications of bone fracture. Even though different treatments have been used to repair nonunion bone defects, most of them have limitations, like morbidities, limited supply, frequent treatment failure, and high cost. Based on the knowledge that MSC have multipotential capacity of differentiation into bone, cartilage, fat, and endothelial cells, and also, play a key role in the process of bone formation and fracture repair. In this study, we evaluated the use the bone regeneration capacity of autologous or allogeneic BM-MSC, as a potential therapeutic strategy to induce formation of new bone tissue and fracture healing. A bioengineering construct, constituted by MSCs and a collagen scaffold, is incorporated into platelet rich plasma (PRP) clot, wich is implanted at the nonunion site defect. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06103396
Study type Interventional
Source Instituto Venezolano de Investigaciones Cientificas
Contact
Status Enrolling by invitation
Phase Phase 1/Phase 2
Start date January 30, 2018
Completion date December 30, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03970941 - Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Terminated NCT00424567 - Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. Phase 1/Phase 2
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Completed NCT00916981 - Treatment of Atrophic Nonunion by Preosteoblast Cells Phase 1/Phase 2
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Not yet recruiting NCT01756144 - rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport N/A
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System